At the same time, it remains completely unclear whether the change in ARL4C level/activity is a consequence of disruptions in the centrosomes’ work, which are often observed in cancer cells due to the violation of the centriolar cycle, or some kind of compensatory mechanism that corrects these disruptions. Here, ARL4C is linked to cancer.